Literature DB >> 22943013

The association between obesity factor and esophageal caner.

Qi Chen, Hengguo Zhuang, Yanhui Liu.   

Abstract

Accumulating epidemiological studies have supported the link between increased body mass index, central obesity and esophageal adenocarcinoma. This association appears stronger than that for other types of obesity-related cancers. Central obesity or visceral fat, more often observed in men, is much more strongly associated with adenocarcinoma than body mass index alone, possibly contributing to the imbalance of disease occurrence between the sexes. Potential mechanisms underlying the association between obesity and esophageal adenocarcinoma have been recently identified, including the insulin-like growth factor pathway, adipokines and sex hormone disturbances. These findings are summarized in this review; however, more research is warranted before these mechanisms are conclusively established.

Entities:  

Keywords:  Esophageal adenocarcinoma; adipokine; insulin; obesity

Year:  2012        PMID: 22943013      PMCID: PMC3418533          DOI: 10.3978/j.issn.2078-6891.2012.026

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  55 in total

1.  Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.

Authors:  Aoife M Ryan; Suzanne P Rowley; Anthony P Fitzgerald; Narayanasamy Ravi; John V Reynolds
Journal:  Eur J Cancer       Date:  2006-04-19       Impact factor: 9.162

2.  Gonadal hormones determine sensitivity to central leptin and insulin.

Authors:  Deborah J Clegg; Lynda M Brown; Stephen C Woods; Stephen C Benoit
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

3.  Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y.

Authors:  D A Ainslie; M J Morris; G Wittert; H Turnbull; J Proietto; A W Thorburn
Journal:  Int J Obes Relat Metab Disord       Date:  2001-11

4.  Body-mass index and symptoms of gastroesophageal reflux in women.

Authors:  Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

5.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 7.  Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

8.  Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study.

Authors:  Audrey H H Merry; Leo J Schouten; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Gut       Date:  2007-03-02       Impact factor: 23.059

9.  Relation of body mass index to cancer risk in 362,552 Swedish men.

Authors:  Claudine Samanic; Wong-Ho Chow; Gloria Gridley; Bengt Jarvholm; Joseph F Fraumeni
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

10.  Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States).

Authors:  Jihyoun Jeon; E Georg Luebeck; Suresh H Moolgavkar
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

View more
  14 in total

1.  Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine.

Authors:  Jun Wang
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 2.  Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  David A Katzka; Rebecca C Fitzgerald
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

3.  Influence of reflux and central obesity on intercellular space diameter of esophageal squamous epithelium.

Authors:  Christopher H Blevins; Anamay N Sharma; Michele L Johnson; Deborah Geno; Milli Gupta; Adil E Bharucha; David A Katzka; Prasad G Iyer
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

Review 4.  Epidemiological studies of esophageal cancer in the era of genome-wide association studies.

Authors:  An-Hui Wang; Yuan Liu; Bo Wang; Yi-Xuan He; Ye-Xian Fang; Yong-Ping Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

6.  Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.

Authors:  Melina Arnold; Amy Colquhoun; Michael B Cook; Jacques Ferlay; David Forman; Isabelle Soerjomataram
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

Review 7.  Sedation Challenges: Obesity and Sleep Apnea.

Authors:  Pichamol Jirapinyo; Christopher C Thompson
Journal:  Gastrointest Endosc Clin N Am       Date:  2016-07

Review 8.  Insulin and cancer: a tangled web.

Authors:  Brooks P Leitner; Stephan Siebel; Ngozi D Akingbesote; Xinyi Zhang; Rachel J Perry
Journal:  Biochem J       Date:  2022-03-18       Impact factor: 3.766

9.  AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1.

Authors:  Chong Chen; Qiuyang Zhang; Sen Liu; Mark Lambrechts; Yine Qu; Zongbing You
Journal:  Front Oncol       Date:  2014-12-01       Impact factor: 6.244

10.  Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer.

Authors:  Nurul Syuhada Ishak; Hanif Abdul Rahman; Shirley H F Lee; Shir Kiong Lu; Lin Naing
Journal:  J Gastrointest Cancer       Date:  2021-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.